Quince Therapeutics (formerly EryDel)
USQuince Therapeutics (formerly EryDel) is a healthcare / biotech company, headquartered in United States.
Entry
2019
Hold
7yr
Status
Active
Est. EV
–
Key facts
HQUnited States
SectorHealthcare / Biotech
US clinical-stage biotech developing erythrocyte delivery systems and other rare disease therapies including eDSP.
See the full ownership history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Full fund context: vintage, strategy, region
Already a member? Sign in
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
France
BelgiumLast updated April 2026 · Sourced from public filings
Italy
UK